Improved Survival in Subset of Advanced Pancreatic Cancer Improved Survival in Subset of Advanced Pancreatic Cancer

Adding nimotuzumab to gemcitabine significantly improved survival outcomes in a subset of patients with KRAS wild-type advanced pancreatic cancer.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news